Antisense & RNAi Therapeutics Market is expected to reach USD 1.81 billion by 2025. RNA therapeutics states to the use of oligonucleotides to target mainly ribonucleic acids (RNA) for research studies to explain functions of genes or therapeutic efforts. Antisense molecules are termed as a synthetic oligodeoxynucleotides (ODN) which are designed in a way that they can hybridize precisely coding mRNA inside the cell. Antisense RNA is always related to RNA interference (RNAi).
Double-stranded RNA fragments
initiate the RNAi process, and this double helix is the actual suppressor of
its equivalent gene. The Antisense & RNAi Therapeutics Market is estimated
to grow at a significant CAGR of 8.6% over the future period as the scope and
its applications are rising enormously across the globe.
Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/antisense-rnai-therapeutics-market/request-sample
Market Synopsis of Antisense & RNAi Therapeutics Market:
Growing occurrence of infectious
diseases, coronary artery diseases, neurodegenerative diseases, and cardiac
ailments, developed research and development sectors, and rising use of
enhanced technology are documented as major factors of Antisense & RNAi Therapeutics
industry that are estimated to enhance the growth in the years to come.
However, toxicity of antisense and RNAi molecules-based drugs may restrain
overall market growth in the coming years. Antisense & RNAi Therapeutics
Market is segmented based on technology, mode of action, application, and
region.
Antisense RNA and RNA
Interference are the enhanced technology used that could be explored in
Antisense & RNAi Therapeutics in the forecast period. RNA interference
includes miRNA and siRNA. RNA Interference technology accounted for the largest
market share and is estimated to lead the overall market in the coming years.
This may be because of advantages of the technology over antisense technology.
The miRNA maintains the cells identity; whereas siRNA allows induction at
enhanced stages of cancer growth.
The mode of action comprises of
topical delivery, pulmonary delivery, intraperitoneal injections, intravenous
injections, intradermal injections, and others could be explored in Antisense
& RNAi Therapeutics in the foremost period. The intravenous route sector
accounts for the largest market share and is estimated to lead the overall
market in the coming years. This may be because liver can be targeted easily by
virtue of an intravenous and fast drug removal without anticipated
pharmacological action.
The market may be categorized
based on applications like infectious diseases, oncology, genetic disorders,
cardiovascular, neurodegenerative disorders, respiratory disorders, renal
diseases, and others. The oncology sector accounted for the largest market
share of Antisense & RNAi Therapeutics and is estimated to lead the overall
market in the coming years.
Globally, North America accounted
for the largest market share of Antisense & RNAi Therapeutics and is
estimated to lead the overall market in the coming years. The reason behind the
overall market growth could be growing number of clinical trials, government
initiative for developing antisense therapeutics, developed research and
development laboratories, and high investment by biotechnology industries for
development of RNAi therapeutic. The United States is a major consumer of
Antisense & RNAi Therapeutics in this region, as presence of key
manufacturers in the region.
View Full Table of Contents of This Report @ https://www.millioninsights.com/industry-reports/antisense-rnai-therapeutics-market
Table of Contents:-
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Antisense & RNAi
Therapeutics: Market Variables, Trends & Scope
Chapter 4 Antisense & RNAi
Therapeutics: Product Estimates & Trend Analysis
Chapter 5 Antisense & RNAi
Therapeutics: Application Estimates & Trend Analysis
Chapter 6 Antisense & RNAi
Therapeutics: End-use Estimates & Trend Analysis
Chapter 7 Antisense & RNAi
Therapeutics: Industrial End-use Estimates & Trend Analysis
Chapter 8 Antisense & RNAi
Therapeutics: Regional Estimates & Trend Analysis
Chapter 9 Competitive Landscape
Chapter 10 Antisense & RNAi
Therapeutics: Manufacturers Company Profiles
Get in touch
At Million Insights, we work with
the aim to reach the highest levels of customer satisfaction. Our
representatives strive to understand diverse client requirements and cater to
the same with the most innovative and functional solutions.
No comments:
Post a Comment